Jeffrey Wade

Track

Insider profile

Currently holds a position at Lexicon Pharmaceuticals Inc

Performance

Overall performance
1.0
Performance over holding periods
1.0
30 days 90 days 120 days
Average return -7% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer, Executive Vice President - Corporate and Administrative Affairs Lexicon Pharmaceuticals Inc Feb. 1, 2015 -
Chief Financial Officer, Executive Vice President - Corporate Development Lexicon Pharmaceuticals Inc May 17, 2010 - Feb. 1, 2015
Jeffrey Wade's trades of Lexicon Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
451.94
Quantity 91,695 -10.8%
Value US$3,733,520
Transaction date
Purchase
Price
118.45
Quantity 93,411 -9.6%
Value US$2,037,527
Transaction date
Purchase
Price
165.77
Quantity 17,792 -41.3%
Value US$4,347,787
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-09-14 2023-09-14
B Purchase
91,695 -10.8%
451.94
US$3,733,520 		91,695 -10.8% 451.94 US$3,733,520
2023-06-20 2023-06-20
B Purchase
93,411 -9.6%
118.45
US$2,037,527 		93,411 -9.6% 118.45 US$2,037,527
2023-06-20 2023-06-20
B Purchase
17,792 -41.3%
165.77
US$4,347,787 		17,792 -41.3% 165.77 US$4,347,787